Suppr超能文献

非典型脑膜瘤的生存预测因素

Predictors of Survival in Atypical Meningiomas.

作者信息

Da Broi Michele, Borrelli Paola, Meling Torstein R

机构信息

Faculty of Medicine, University of Oslo, 0372 Oslo, Norway.

Department of Neurosurgery, Oslo University Hospital, 0372 Oslo, Norway.

出版信息

Cancers (Basel). 2021 Apr 21;13(8):1970. doi: 10.3390/cancers13081970.

Abstract

INTRODUCTION

Predictors of survival and progression of disease in atypical meningiomas are less well documented in the literature compared to benign meningiomas. Higher grade meningiomas tend to recur often and one of the most critical aspects is how to best deal with relapses.

METHODS

A total of 77 consecutive patients who underwent craniotomy for atypical meningioma between 1990-2010 at Oslo University Hospital (OUH) were reviewed.

RESULTS

Median age at surgery was 62.21 [interquartile range (IQR): 22.87] years. Fifty-one patients (66.2%) had neurological deficits at presentation. Fifty-four patients (70.1%) underwent gross total resection (GTR). Thirty-nine patients (50.7%) had improved/stable neurological outcomes at 6-12 months. Twenty-two patients (28.6%) underwent retreatment, of whom 20 (26.0%) were subjected to resection followed by adjuvant radiotherapy. Overall survival (OS) was significantly longer in patients <65 years ( < 0.001), with preoperative Karnofsky performance scale (KPS) score of ≥ 70 ( = 0.006), and who required no retreatment ( = 0.033). GTR significantly prolonged the retreatment-free survival rate ( < 0.001). STR carried almost a six-fold greater risk of neurological outcome deterioration ( = 0.044).

CONCLUSIONS

GTR significantly prolonged retreatment-free survival but had no significant impact on OS. STR was a significant risk factor for deteriorated neurological outcome. Age, preoperative KPS, and retreatment were all strong predictors of OS. Median time-to-retreatment (TTR) did not shorten significantly throughout repeated surgeries.

摘要

引言

与良性脑膜瘤相比,非典型脑膜瘤疾病生存和进展的预测因素在文献中的记载较少。高级别脑膜瘤往往容易复发,最关键的问题之一是如何最好地应对复发情况。

方法

回顾了1990年至2010年间在奥斯陆大学医院(OUH)接受开颅手术治疗非典型脑膜瘤的77例连续患者。

结果

手术时的中位年龄为62.21岁[四分位间距(IQR):22.87]。51例患者(66.2%)在就诊时存在神经功能缺损。54例患者(70.1%)接受了全切除(GTR)。39例患者(50.7%)在6至12个月时神经功能结局改善/稳定。22例患者(28.6%)接受了再次治疗,其中20例(26.0%)接受了切除并辅助放疗。年龄<65岁(<0.001)、术前卡诺夫斯基表现评分(KPS)≥70分(=

0.006)且无需再次治疗的患者(= 0.033)总体生存期(OS)明显更长。GTR显著延长了无再次治疗生存期(<0.001)。次全切除(STR)使神经功能结局恶化的风险几乎增加了六倍(= 0.044)。

结论

GTR显著延长了无再次治疗生存期,但对OS无显著影响。STR是神经功能结局恶化的重要危险因素。年龄、术前KPS和再次治疗均是OS的有力预测因素。在整个重复手术过程中,中位再次治疗时间(TTR)没有显著缩短。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/531d/8074901/6324a951e18f/cancers-13-01970-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验